CLINICAL_TRIALS
trial_result
· 2017-04-07
Clinical Trial Update: Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer [Phase 2]
Summary
Phase 2 trial investigating pimasertib with SAR245409 or placebo in ovarian cancer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-07